Equation Info

Industry Medical Equipment & Supplies
Sector Healthcare
52-week range
07/14/05 – 05/23/06 1.19 -3.35
Common Shares Outstanding
Current Ratio (mrq)
Average Volume (3 month) 37,300
Book Value Per Share (mrq) 0.69
Total Debt/Equity (mrq) 0.137
Total Cash Per Share (mrq) 0.342
Total Cash (mrq) 11.4M
Fiscal Year End
December 31

mrq = most-recent quarter
Date Sunday, Oct. 20, 2019
Regarding the information on this page and contained within the SEC and stock quote links contained in this web site:

SEC/EDGAR Disclaimer
You can review the filings EP MedSystems has made with the U.S. Securities and Exchange Commission (“SEC”) by linking directly to EDGAR (Electronic Data Gathering, Analysis and Retrieval system), a database maintained by the SEC. EDGAR is not part of the EP MedSystems Web site and this link to EDGAR does not mean that EP MedSystems endorses or accepts any responsibility for the content, or the use, of EDGAR. The EDGAR link provided is for informational purposes only, and is not intended for trading or investment purposes. EP MedSystems does not guarantee the sequence, accuracy, or completeness of any information or data displayed through EDGAR, nor shall EP MedSystems be liable in any way to the reader or to any other person, firm or corporation whatsoever for any delays, inaccuracies, errors in, or omission of any such information or data or the transmission thereof, or for any actions taken in reliance thereon or for any damages arising therefrom or occasioned thereby or by reason of nonperformance or interruption, or termination, of the information or data for any cause whatsoever. EP MedSystems does not assume any duty of disclosure beyond that which is imposed by law, and expressly disclaims any duty to update any information set forth in its filings with the SEC. The reader should note that EP MedSystems’ periodic reports filed with the SEC include the disclosure therein of certain factors which may affect EP MedSystems’ future performance. Individual statements appearing in EP MedSystems’s SEC filings are intended to be read in conjunction with and in the context of the complete documents in which they appear, to include any documents incorporated therein by reference thereto, rather than as stand-alone statements.